1. Definition and Scope of AI-TDS™ Technology
AI-TDS™ is a proprietary manufacturing and formulation-development technology implemented within our production facilities.
It is not a formulation system or a finished product, but a technology framework that governs how formulations are designed, processed, stabilized, and assembled.
AI-TDS™ operates across the entire formulation lifecycle, from pre-laboratory design decisions to controlled manufacturing execution. Its objective is to reduce variability,increase predictability, and optimize functional performance of advanced formulations intended for biological application.
The technology is structured around four scientific pillars, each addressing a critical and complementary stage of formulation development and processing.
2. Pillar I — AI-Assisted Sequence Optimization
Methodological Framework
In complex formulations, ingredient order, processing sequence, and exposure conditions strongly influence molecular interactions, hydration behavior, and overall stability. Small variations in sequence can lead to aggregation, loss of functional activity, or reduced reproducibility.
AI-assisted sequence optimization applies predictive, algorithm-guided modeling to evaluate multiple formulation pathways prior to laboratory or manufacturing execution. The methodology assesses:
- ingredient–ingredient interaction probability
- compatibility under defined processing conditions
- risks of physicochemical instability, including precipitation, degradation, or phase separation
Based on these analyses, the optimal sequence and processing conditions are selected before physical formulation.
Functional Impact
- Enhances ingredient compatibility within the final formulation by selecting the optimal order of incorporation.
- Improves structural homogeneity, reducing micro-heterogeneity and localized instability.
- Minimizes risks of ingredient inactivation, aggregation, or antagonistic interactions in the finished product.
- Optimizes functional performance of actives by ensuring they are incorporated under conditions that preserve their integrity.
- Contributes to consistent physicochemical behavior of the final formulation under intended conditions of use.
- Supports predictable biological and mechanical performance by controlling interaction pathways established during formulation.
This pillar ensures that the final product composition, structure, and performance are optimized at the molecular and formulation level, rather than being the result of empirical sequencing choices.
3. Pillar II — Thermal Stabilization of Hyaluronic Acid
Methodological Framework
Hyaluronic acid (HA) is a key structural and functional component in many advanced formulations. In non-crosslinked systems, physical consistency and molecular organization must be optimized without altering chemical identity or introducing crosslinking agents.
Thermal stabilization is a controlled physical processing step applied specifically to hyaluronic acid. Defined temperature and exposure parameters promote:
- improved molecular organization
- enhanced consistency and uniformity
- preservation of native molecular structure and molecular weight distribution
No chemical crosslinking or reactive agents are used.
Thermally stabilized hyaluronic acid serves as a foundational component across most formulations, providing a standardized and reliable structural base.
Functional Impact
- Improves formulation uniformity and consistency
- Enhances resistance to processing related instability
- Maintains high biocompatibility and physiological affinity
- Supports reproducible performance across multiple products
This pillar provides platform level consistency, which is essential for clinically reliable and advanced formulations.
4. Pillar III — Dynamic Rheology
Methodological Framework
Beyond chemical composition, mechanical behavior under physiological forces is a key determinant of product performance in biological environments. This is particularly relevant for biostimulatory and non-crosslinked formulations, where behavior must be controlled without relying on permanent structural networks.
Dynamic rheology describes the reversible mechanical response of a formulation to applied stress.
- In the laboratory, dynamic rheology is defined through controlled rheological testing under physiologically relevant conditions, characterizing response to mechanical stress and recovery behavior.
- In vivo, it refers to the formulation’s ability to adapt mechanically to tissue-related forces while maintaining structural and compositional consistency, allowing selected components to interact with the biological environment over time according to their physiological stability profiles.
Dynamic rheology describes mechanical adaptation, not chemical change, degradation, or formulation instability.
Functional Impact
- Ensures predictable mechanical behavior under physiological conditions
- Supports consistent structural performance after placement
- Enhances compatibility with natural tissue movement
- Allows selected components to remain functionally active over time without compromising formulation integrity
This pillar ensures controlled and biologically compatible mechanical performance.
5. Pillar IV — Sequential Assembly with Selective Pre-Hydration
Methodological Framework
Sensitive or functional ingredients may lose activity or stability if exposed prematurely to incompatible conditions during formulation. Uncontrolled mixing can reduce efficacy, homogeneity, and reproducibility.
Sequential assembly is a controlled manufacturing strategy in which:
- ingredients are incorporated step-by-step in a predefined order
- sensitive actives are selectively pre-hydrated under optimized conditions prior to integration
- exposure to destabilizing environments is minimized
This ensures each ingredient enters the formulation under conditions compatible with its stability and functional role.
Functional Impact
- Preserves functional integrity of sensitive components
- Improves formulation homogeneity
- Enhances long-term stability and performance
- Enables precise control over ingredient compatibility and synergy
This pillar ensures precision manufacturing and functional consistency.
6. System-Level Scientific Value of AI-TDS™
When applied together, the four AI-TDS™ pillars create a controlled, reproducible, and optimized formulation pathway:
- AI-assisted optimization defines formulation strategy
- Thermal stabilization standardizes the structural base
- Dynamic rheology controls mechanical behavior in biological environments
- Sequential assembly preserves ingredient functionality
The result is a formulation that is scientifically rational, mechanically controlled, biologically compatible, and manufacturing robust.
7. Conclusion
AI-TDS™ is apatented technology that controls how a formulation is built, not only which ingredients are used.
Unlike conventional formulations, which are typically developed by standard mixing and empirical adjustment, AI-TDS™ defines ingredient interactions, structural organization, and mechanical behavior during formulation design.
Because the final product properties are created through this unique, protected formulation pathway, the resulting formulation shows more consistent structure, predictable behavior in the body, and controlled biological interaction. These characteristics cannot be reproduced by regular formulation methods, which is why the technology and its resulting product outcomes are protected by patent.